290328-53-9

Basic information

• Product Name: 4-[(Methylsulfonyl)Methyl]piperidine hcl
• Synonyms: 4-[(Methylsulfonyl)Methyl]piperidine hcl
• CAS NO: 290328-53-9
• Molecular Formula: C7H16ClNO2S
• Molecular Weight: 213.72544
• Mol File: 290328-53-9.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-[(Methylsulfonyl)Methyl]piperidine hcl(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(Methylsulfonyl)Methyl]piperidine hcl(290328-53-9)
• EPA Substance Registry System: 4-[(Methylsulfonyl)Methyl]piperidine hcl(290328-53-9)

Safety Data

• Hazardous Substances Data: 290328-53-9(Hazardous Substances Data)

Upstream product

• 194872-09-8 4-(methylsulfonylmethyl)piperidine-1-carboxylic acid tert-butyl ester 
• 597563-38-7 4-(methylthiomethyl)piperidine-1-carboxylic acid tert-butyl ester 
• 123855-51-6 tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate 
• 161975-39-9 tert-butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate 

Downstream Products

• 1445902-04-4 N-isobutyl-N-[4-(4-((methylsulfonyl)methyl)piperidin-1-yl)benzyl]-1-phenylmethanesulfonamide 

Relevant articles and documents

ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS

The present invention relates to a compound represented by formula I: and pharmaceutically acceptable salts thereof. The compounds of formula I are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.